Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)
NCT00231439
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Post-Polio Syndrome
Interventions
DRUG:
IvIg
Sponsor
Haukeland University Hospital